A 55-yr-old post-menopausal woman with osteopenia and no history of
breast disease is presented. She was placed on raloxifene HCl 60 mg and
soon after developed severe breast pain. The follow-up mammogram,
performed prematurely at 6 months, showed a marked increase in breast
density. Therapy was accordingly stopped and mastodynia subsided. The
patient’s mammogram regressed to pre-treatment status after 6 months
off-therapy. (C) 2002, Editrice Kurtis